Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Gastroenterology and Hepatology. 2023; 8(9):803-815.
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. The Lancet Gastroenterology and Hepatology. 2023; 8(5):408-421.
Molecular analysis of duodenal eosinophilia. Journal of Allergy and Clinical Immunology. 2023; 151(4):1027-1039.
Mast cell-pain connection in eosinophilic esophagitis. Allergy. European Journal of Allergy and Clinical Immunology. 2022; 77(6):1895-1899.
Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study. Gastroenterology. 2022; 162(6):1635-1649.
Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk. Gastroenterology. 2022; 162(2):439-453.
Diagnostic merits of the Eosinophilic Esophagitis Diagnostic Panel from a single esophageal biopsy. Journal of Allergy and Clinical Immunology. 2022; 149(2):782-787.e1.
Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitis. Nature Communications. 2021; 12(1):6795.
Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study. Journal of Allergy and Clinical Immunology. 2020; 145(1):255-269.
Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study. The Lancet Gastroenterology and Hepatology. 2018; 3(7):477-488.
Epigenetic and transcriptional programming of murine eosinophils in the esophagus. Nature Communications. 2025; 16(1):10454.
Involvement of IL-13-Induced Dysregulation of BDNF-NTRK2 Pathway in Symptoms of Eosinophilic Esophagitis. Allergy. European Journal of Allergy and Clinical Immunology. 2025; 80(10):2894-2897.
One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: A multisite randomized trial. Journal of Allergy and Clinical Immunology. 2025; 155(2):520-532.
Nonepithelial Gene Expression Correlates With Symptom Severity in Adults With Eosinophilic Esophagitis. Journal of Allergy and Clinical Immunology: In Practice. 2024; 12(12):3346-3355.e1.
Induction of sustained remission and reversal of pathologic transcriptome achieved with tezepelumab in an adolescent with eosinophilic esophagitis. Journal of Allergy and Clinical Immunology: In Practice. 2024; 12(11):3147-3149.e2.
Advances in omics data for eosinophilic esophagitis: moving towards multi-omics analyses. Journal of Gastroenterology. 2024; 59(11):963-978.
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis. Journal of Allergy and Clinical Immunology: In Practice. 2024; 12(9):2427-2438.e3.
Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis. Journal of Allergy and Clinical Immunology. 2024; 154(2):375-386.e4.
Eosinophil Involvement Outside the Esophagus in Eosinophilic Esophagitis. Clinical Gastroenterology and Hepatology. 2024; 22(7):1531-1534.e2.
Common and disparate clinical presentations and mechanisms in different eosinophilic gastrointestinal diseases. Journal of Allergy and Clinical Immunology. 2024; 153(6):1472-1484.
Persistent esophageal changes after histologic remission in eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 2024; 153(4):1063-1072.
The minichromosome maintenance complex drives esophageal basal zone hyperplasia. JCI Insight. 2023; 8(17).
Prospective study of an amino acid-based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial. Journal of Allergy and Clinical Immunology. 2023; 152(3):676-688.
Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Gastroenterology and Hepatology. 2023; 8(9):803-815.
Local type 2 immunity in eosinophilic gastritis. Journal of Allergy and Clinical Immunology. 2023; 152(1):136-144.
Vitamin D receptor and STAT6 interactome governs oesophageal epithelial barrier responses to IL-13 signalling. Gut. 2023; 72(5):834-845.
Genetic and Molecular Contributors in Eosinophilic Esophagitis. Current Allergy and Asthma Reports. 2023; 23(5):255-266.
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. The Lancet Gastroenterology and Hepatology. 2023; 8(5):408-421.
Molecular analysis of duodenal eosinophilia. Journal of Allergy and Clinical Immunology. 2023; 151(4):1027-1039.
Epithelial cell-expressed type II IL-4 receptor mediates eosinophilic esophagitis. Allergy. European Journal of Allergy and Clinical Immunology. 2023; 78(2):464-476.
Strong association of mast cells with eosinophilic esophagitis-specific signatures. Allergy. European Journal of Allergy and Clinical Immunology. 2023; 78(2):583-586.
Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission. Journal of Allergy and Clinical Immunology. 2022; 149(6):2062-2077.
Mast cell-pain connection in eosinophilic esophagitis. Allergy. European Journal of Allergy and Clinical Immunology. 2022; 77(6):1895-1899.
Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study. Gastroenterology. 2022; 162(6):1635-1649.
Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort. American Journal of Gastroenterology. 2022; 117(3):413-423.
Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk. Gastroenterology. 2022; 162(2):439-453.
Diagnostic merits of the Eosinophilic Esophagitis Diagnostic Panel from a single esophageal biopsy. Journal of Allergy and Clinical Immunology. 2022; 149(2):782-787.e1.
Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitis. Nature Communications. 2021; 12(1):6795.
Type 2 Immunity and Age Modify Gene Expression of Coronavirus-induced Disease 2019 Receptors in Eosinophilic Gastrointestinal Disorders. Journal of Pediatric Gastroenterology and Nutrition. 2021; 72(5):718-722.
Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants. Journal of Allergy and Clinical Immunology. 2021; 147(1):244-254.e6.
Eosinophilic esophagitis with extremely high esophageal eosinophil counts. Journal of Allergy and Clinical Immunology. 2021; 147(1):409-412.e5.